Efficacy of Tumor Treating Fields (TTFields) in mesothelioma is associated with reduced capacity for DNA damage repair.

被引：0
|
作者：
Mumblat, Helena [1 ]
Martinez, Antonia [1 ]
Braten, Ori [1 ]
Munster, Mijal [1 ]
Dor-On, Eyal [1 ]
Schneiderman, Rosa S. [1 ]
Porat, Yaara [1 ]
Voloshin, Tali [1 ]
Davidi, Shiri [1 ]
Blatt, Roni [1 ]
Shteingauz, Anna [1 ]
Tempel-Brami, Catherine [1 ]
Zeevi, Einav [1 ]
Lajterer, Carolina [1 ]
Shmueli, Yuval [1 ]
Danilov, Shiri [1 ]
Haber, Adi [1 ]
Giladi, Moshe [1 ]
Kinzel, Adrian [2 ]
Weinberg, Uri [1 ]
Palti, Yoram [1 ]
机构：
[1] Novocure, Haifa, Israel
[2] Novocure GmbH, Munich, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1186
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy of combining tumor treating fields (TTFields) with a PARP inhibitor in ovarian cell lines
    Mulvey, Brett
    Martinez-Conde, Antonia
    Efimov, Vera
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S158 - S158
  • [22] Newly identified role of tumor treating fields in DNA damage repair and replication stress pathways
    Karanam, Narasimha Kumar
    Ding, Lianghao
    Sishc, Brock
    Saha, Debabrata
    Story, Michael D.
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models
    Mumblat, Helena
    Martinez-Conde, Antonia
    Braten, Ori
    Munster, Mijal
    Dor-On, Eyal
    Schneiderman, Rosa S.
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Blatt, Roni
    Shteingauz, Anna
    Tempel-Brami, Catherine
    Zeevi, Einav
    Lajterer, Carolina
    Shmueli, Yuval
    Danilov, Shiri
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Kinzel, Adrian
    Palti, Yoram
    LUNG CANCER, 2021, 160 : 99 - 110
  • [24] The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed inhibit mesothelioma cells in vitro
    Munster, Mijal
    Schneiderman, Rosa
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Shteingauz, Anna
    Kayna, Noa
    Zeevi, Einav
    Gotlib, Karnit
    Giladi, Moshe
    Kirson, Eilon
    Weinberg, Uri
    Kinzel, Adrian
    Palti, Yoram
    CANCER RESEARCH, 2019, 79 (13)
  • [25] The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed Inhibit Mesothelioma Cells In Vitro
    Munster, M.
    Schneiderman, R. S.
    Porat, Y.
    Voloshin, T.
    Davidi, S.
    Shteingauz, A.
    Kaynan, N.
    Zeevi, E.
    Gotlib, K.
    Giladi, M.
    Kirson, E.
    Weinberg, U.
    Kinzel, A.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 239 - 239
  • [26] Safety and efficacy of Tumor Treating Fields (TTFields) combined with bevacizumab and systemic chemotherapy in recurrent GBM
    Kang, Xun
    Cai, Zehao
    Chen, Feng
    Zhang, Botao
    Jiang, Bo
    Li, Wenbin
    CANCER RESEARCH, 2023, 83 (08)
  • [27] Preclinical efficacy of Tumor Treating Fields (TTFields) applied with PARP inhibitors or carboplatin in ovarian cancer
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Frechtel-Gerzi, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (01)
  • [28] TARGETING THE CELL-CYCLE EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) TO INCREASE ITS EFFICACY
    Slangen, Paul
    Elbakary, Basma
    Van Mil, Lotte
    De Gooijer, Mark
    Krenning, Lenno
    Van den Broek, Bram
    Mertz, Marjolijn
    Van Tellingen, Olaf
    Borst, Gerben
    NEURO-ONCOLOGY, 2022, 24 : 38 - 38
  • [29] In vitro and in vivo efficacy and safety of tumor treating fields (TTFields) and sorafenib combination in hepatocellular carcinoma
    Davidi, Shiri
    Tempel-Brami, Catherine
    Munster, Mijal
    Gotlib, Karnit
    Zeevi, Einav
    Schneiderman, Rosa S.
    Voloshin, Tali
    Giladi, Moshe
    Kinzel, Adrian
    Kirson, Eilon D.
    Weinberg, Uri
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [30] Underlining mechanism for the efficacy of tumor treating fields (TTFields) concomitant with sorafenib for treatment of hepatocellular carcinoma
    Davidi, S.
    Jacobovitch, S.
    Shteingauz, A.
    Tempel-Brami, C.
    Munster, M.
    Zeevi, E.
    Dor-On, E.
    Schneiderman, R.
    Voloshin, T.
    Haber, A.
    Giladi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S162 - S163
12345